Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma

MLA

Alvin H.W. Fong, et al. “Application of Circulating Plasma/Serum EBV DNA in the Clinical Management of Nasopharyngeal Carcinoma.” Oral Oncology, vol. 50, June 2014, pp. 527–38. EBSCOhost, https://doi.org/10.1016/j.oraloncology.2013.12.011.

APA

Alvin H.W. Fong, Stephen C.K. Law, Roger K.C. Ngan, & Timothy T.C. Yip. (2014). Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma. Oral Oncology, 50, 527–538. https://doi.org/10.1016/j.oraloncology.2013.12.011

Chicago

Alvin H.W. Fong, Stephen C.K. Law, Roger K.C. Ngan, and Timothy T.C. Yip. 2014. “Application of Circulating Plasma/Serum EBV DNA in the Clinical Management of Nasopharyngeal Carcinoma.” Oral Oncology 50 (June): 527–38. doi:10.1016/j.oraloncology.2013.12.011.